Myotonic dystrophy – Life with Disease

Go back

Myotonic dystrophy is a complex inherited condition that progressively weakens muscles and affects multiple body systems, making everyday tasks increasingly challenging as the disease advances over time.

Understanding the Outlook: What to Expect

When someone receives a diagnosis of myotonic dystrophy, one of the first questions that arises concerns what the future holds. The outlook for people living with this condition varies greatly from person to person, making it difficult for doctors to predict exactly how the disease will affect any individual. This uncertainty can be difficult to accept, but understanding the general patterns can help with planning and preparation.[1]

The severity of myotonic dystrophy depends largely on which type a person has and when symptoms first appear. Classic myotonic dystrophy type 1, which typically begins in a person’s twenties, thirties, or forties, tends to be more severe than type 2, which usually starts later in adulthood. The congenital form, present at birth, represents the most serious variation and can be life-threatening in the early years of life.[1]

Research tracking people with myotonic dystrophy type 1 over time has revealed sobering statistics about life expectancy. In one study that followed 367 patients over a ten-year period, 20% of participants died during that timeframe, with the average age at death being 53.2 years. The leading causes of death were respiratory complications, accounting for 43% of deaths, followed by heart-related problems at 20%, cancer at 11%, and sudden unexplained death at 11%.[11]

Patients with congenital, childhood, and classic adult-onset myotonic dystrophy type 1 face higher risks for early mortality. The most critical health concerns involve breathing difficulties and heart rhythm problems, both of which require careful monitoring throughout life. These complications underscore why regular medical follow-up is so important for anyone living with this condition.[11]

⚠️ Important
Many people living with myotonic dystrophy experience only mild symptoms that progress slowly over many years. Some individuals may develop only minor muscle weakness or cataracts late in life. The disease affects each person differently, and having a diagnosis does not automatically mean experiencing severe disability.

At the opposite end of the spectrum, many people with myotonic dystrophy lead relatively normal lives with manageable symptoms. Often, the disorder manifests as mild muscle weakness or cataracts that appear later in life. The wide range of possible outcomes makes it impossible to paint everyone with the same brush, and this variability extends even within families where multiple members carry the genetic mutation.[12]

How the Disease Progresses Without Treatment

Understanding how myotonic dystrophy naturally develops over time helps people and their families prepare for changes that may occur. The hallmark feature of this condition is that it is progressive, meaning symptoms gradually worsen as years pass. However, the rate of progression differs dramatically between individuals and between the different types of myotonic dystrophy.[1]

The three main symptoms that define myotonic dystrophy and typically worsen over time are muscle wasting, muscle weakness, and myotonia—the inability to relax muscles after contracting them. For example, someone with myotonia might have difficulty releasing their grip after shaking hands or opening their hand after making a fist. This peculiar symptom often becomes more noticeable after rest and tends to improve with repeated muscle activity, though it generally persists throughout life.[1]

In classic myotonic dystrophy type 1, which begins in adulthood, the initial symptoms usually involve myotonia and weakness in the distal muscles—those farthest from the center of the body, such as the hands, forearms, feet, and lower legs. Over time, this weakness spreads to affect more muscle groups. People may notice difficulty with fine motor tasks like buttoning shirts or picking up small objects. Walking becomes affected as foot drop develops, causing a characteristic shuffling or high-stepping gait pattern.[1]

Facial muscles gradually waste away, creating a distinctive thin, elongated facial appearance sometimes called a myopathic face. The muscles responsible for chewing and swallowing can weaken, leading to difficulties eating and increased risk of choking. Speech may become slurred as the tongue and facial muscles lose strength. These changes in appearance and function can be distressing, affecting not only physical capabilities but also social interactions and self-image.[1]

Beyond the muscles used for movement, myotonic dystrophy affects smooth muscles—the involuntary muscles in organs throughout the body. The digestive system frequently becomes involved, causing constipation, diarrhea, or difficulties with swallowing. The gallbladder and intestines may not function normally, leading to abdominal pain and digestive complaints. These internal symptoms can be just as troublesome as the more visible muscle weakness, though they are often less recognized.[5]

The heart is particularly vulnerable in myotonic dystrophy, with cardiac conduction abnormalities developing in many patients. These electrical problems interfere with the heart’s normal rhythm, potentially causing the heart to beat too slowly, irregularly, or even to stop temporarily. Unlike muscle weakness that progresses gradually, heart problems can appear suddenly and without warning, which is why cardiac monitoring is considered essential even in people with otherwise mild symptoms.[1]

Vision problems also emerge as the disease progresses. Cataracts—clouding of the eye’s lens—develop earlier than would normally be expected, often appearing before age 50. Many people with myotonic dystrophy also experience drooping eyelids, which can interfere with vision and contribute to a tired appearance. These eye changes usually worsen gradually but can often be corrected with surgery when they become problematic.[5]

Breathing muscles gradually weaken over the course of the disease, particularly in myotonic dystrophy type 1. This respiratory muscle weakness may not be immediately obvious but becomes significant over time. People may notice shortness of breath with minimal exertion, difficulty taking deep breaths, or morning headaches caused by carbon dioxide buildup during sleep. Sleep-related breathing problems are especially common, with many patients developing obstructive sleep apnea or experiencing diminished breathing drive during sleep.[10]

The endocrine system—the body’s hormone-producing glands—often becomes affected as myotonic dystrophy progresses. Diabetes may develop, requiring monitoring of blood sugar levels and potentially medication. In men, testosterone levels may drop, leading to reduced fertility, early balding, and decreased muscle mass. In women, menstrual irregularities and fertility problems may occur. These hormonal changes add another layer of complexity to managing the condition.[4]

Complications That May Arise

Beyond the expected progression of muscle weakness and other primary symptoms, myotonic dystrophy can lead to several serious complications that require vigilant monitoring and prompt treatment when they occur. These complications often pose the greatest health risks and account for much of the reduced life expectancy seen in people with this condition.[11]

Respiratory complications represent one of the most serious concerns for people with myotonic dystrophy type 1. As breathing muscles weaken, the lungs cannot fully expand and contract, making it difficult to take deep breaths and cough effectively. This weakness increases the risk of developing pneumonia, as secretions cannot be cleared properly from the lungs. Aspiration—when food or liquid enters the lungs instead of the stomach—becomes more likely as swallowing muscles weaken, further increasing pneumonia risk.[11]

Sudden cardiac death is a frightening possibility in myotonic dystrophy, occurring without warning in some patients. The heart’s electrical system can develop severe conduction blocks, where signals fail to travel properly through the heart muscle. This can cause the heart to beat dangerously slowly or stop altogether. These cardiac events can happen even in people with mild muscle symptoms, which is why experts recommend regular heart monitoring for all people with myotonic dystrophy regardless of how mildly affected they may appear.[10]

⚠️ Important
General anesthesia poses unusually high risks for people with myotonic dystrophy type 1, with reports of complications and even deaths during surgery. Even people with mild symptoms face these risks. Always inform your entire surgical team, especially the anesthesiologist, about your myotonic dystrophy diagnosis well before any planned procedure. Certain anesthesia medications, particularly succinylcholine, must be avoided.

Anesthesia complications deserve special attention because they can occur during routine surgical procedures. People with myotonic dystrophy have heightened sensitivity to anesthesia medications and face increased risks during and after surgery. Problems can include difficulty breathing, prolonged muscle contractions triggered by certain drugs, trouble waking up after surgery, and dangerous heart rhythm disturbances. Regional anesthesia (numbing only part of the body) may be safer than general anesthesia for some procedures, but careful monitoring is essential regardless of the approach chosen.[10]

Choking and swallowing difficulties can lead to dangerous situations. As the muscles involved in swallowing weaken, food and liquid may go down the wrong way, entering the airway instead of the esophagus. This not only causes immediate distress but can lead to aspiration pneumonia, a serious lung infection. Some people require modifications to food textures or, in severe cases, feeding tubes to ensure adequate nutrition while minimizing aspiration risk.[13]

Falls and injuries become more frequent as muscle weakness progresses. Weakness in the legs and feet, combined with foot drop and impaired balance, increases the likelihood of tripping and falling. These falls can result in fractures, head injuries, and other trauma. The risk is compounded by excessive daytime sleepiness, which affects alertness and reaction time. Taking preventive measures like removing tripping hazards at home and using assistive devices becomes increasingly important as weakness advances.[13]

Cognitive and behavioral issues can emerge or worsen over time, though these are more common in congenital and childhood-onset forms. Adults may experience excessive sleepiness that interferes with daily functioning, difficulty with planning and organization, and lack of initiative. Some people develop depression or anxiety, which may be related both to coping with a progressive illness and to direct effects of the disease on brain function. These cognitive changes can be subtle and may not be immediately recognized as disease-related.[3]

Pregnancy carries special risks for women with myotonic dystrophy. The condition can worsen during pregnancy, and there are increased risks of complications including premature labor, excessive bleeding after delivery, and prolonged labor due to weak uterine muscles. If the mother passes the genetic mutation to her baby, there is a risk the child will be born with the severe congenital form of the disease. For these reasons, pregnancy in women with myotonic dystrophy is considered high-risk and requires specialized obstetric care.[4]

Impact on Daily Living

Living with myotonic dystrophy means adapting to a body that gradually changes, making tasks that once seemed effortless increasingly challenging. The disease touches virtually every aspect of daily life, from basic self-care activities to work, hobbies, relationships, and social participation. Understanding these impacts helps people and families plan strategies to maintain quality of life as the condition progresses.[13]

Physical activities become progressively more difficult as muscle weakness advances. Simple morning routines like getting out of bed, bathing, dressing, and preparing breakfast require more time and effort. Buttoning shirts, tying shoes, and handling small objects become frustrating challenges as hand muscles weaken. Many people find they need to switch to clothing with velcro or elastic waistbands and shoes that slip on easily. What once took minutes may now require significantly longer, and some tasks may eventually require assistance from others.[13]

Walking and mobility deteriorate over time in most people with classic myotonic dystrophy type 1. Foot drop causes the toes to catch on rugs or uneven pavement, increasing fall risk. Stairs become daunting obstacles as leg muscles weaken. Long distances that were once manageable become impossible without rest breaks. Many people eventually need assistive devices like ankle-foot braces to stabilize weak ankles, canes or walkers for balance support, or wheelchairs or scooters for longer distances.[8]

Employment presents significant challenges for many people with myotonic dystrophy. Physical jobs become impossible as strength declines. Even sedentary work can be affected by excessive daytime sleepiness, difficulty concentrating, slowed thinking, and reduced stamina. Frequent medical appointments cut into work time. Many people find they need to reduce their hours, change to less demanding positions, or eventually stop working altogether. The loss of employment affects not only income but also sense of purpose, social connections, and self-esteem.[13]

Driving safety becomes a concern as the disease progresses. Muscle weakness may interfere with the physical aspects of driving, such as turning the steering wheel, pressing pedals, or checking blind spots. More concerning is the excessive sleepiness that affects many people with myotonic dystrophy, which dramatically increases accident risk. Some people with myotonic dystrophy have been reported to fall asleep while driving. Recognizing when it is no longer safe to drive requires honest self-assessment and may mean surrendering independence before being ready emotionally.[12]

Hobbies and recreational activities often need to be modified or abandoned as physical capabilities change. Someone who enjoyed hiking may need to switch to shorter walks on level ground. A musician may struggle to play instruments as hand coordination deteriorates. Gardeners may need raised beds and lightweight tools. Finding new activities that match current abilities helps maintain engagement with life, though letting go of beloved pastimes involves grief and adjustment.[13]

Social relationships experience strain under the weight of chronic illness. Friends may drift away, uncomfortable with changed physical appearance or uncertain how to help. Social activities become logistically complicated when mobility is limited, fatigue is overwhelming, or medical equipment is needed. Some people with myotonic dystrophy withdraw socially, either because activities are too difficult or because they feel self-conscious about their appearance or limitations. Maintaining social connections requires effort from both the person with the condition and their social circle.[13]

Intimate relationships and family dynamics shift as myotonic dystrophy progresses. Partners often gradually transition from equal partners to caregivers, a change that can strain even strong relationships. The person with myotonic dystrophy may feel guilty about increasing dependency, while the partner may feel overwhelmed by caregiving responsibilities. Sexual function can be affected by hormone changes, muscle weakness, fatigue, and emotional factors. Open communication becomes crucial, though discussing these changes can be difficult.[13]

Emotional well-being fluctuates as people adapt to losses and changes. Periods of grief, frustration, and anger are normal responses to progressive disability. Many people with myotonic dystrophy experience depression, which may be both a reaction to their situation and potentially a direct effect of the disease on brain chemistry. Anxiety about the future, particularly regarding cardiac risks and disease progression, weighs heavily on many minds. Access to mental health support and counseling can make a significant difference in emotional adjustment.[13]

Coping strategies that help maintain quality of life include pacing activities to manage fatigue, using assistive devices without shame, asking for and accepting help from others, connecting with others who understand through support groups, focusing on abilities rather than losses, and maintaining as much control and independence as possible in daily decisions. Adapting expectations as circumstances change, rather than fighting against limitations, helps reduce frustration and disappointment.[12]

Financial concerns add stress to an already challenging situation. Medical care, assistive equipment, home modifications, and potentially paid caregiving create significant expenses. Loss of employment reduces income precisely when needs increase. Navigating disability benefits, insurance coverage, and financial assistance programs requires time and energy that may already be in short supply. Financial planning becomes essential, yet difficult when the future course of the disease is uncertain.[12]

Supporting Family Members Through Clinical Trial Participation

Families play a crucial role when a loved one considers participating in clinical trials for myotonic dystrophy. While there is currently no treatment that slows the progression of the disease, numerous research studies are underway testing potential therapies. Clinical trials offer hope for future treatments while advancing scientific understanding of this complex condition. Family support can make the difference between successfully participating in research or missing opportunities that might benefit both the individual and others with the condition.[8]

Understanding what clinical trials involve helps families provide informed support. Clinical trials are carefully designed research studies that test whether new treatments are safe and effective. Some trials test medications, while others might evaluate physical therapy approaches, assistive devices, or ways to manage specific symptoms. Each trial has specific requirements about who can participate, what the study involves, how long it lasts, and what potential risks and benefits exist. Trials are voluntary, and participants can withdraw at any time if they choose.[15]

Finding appropriate clinical trials can feel overwhelming, especially when someone is already dealing with the demands of managing myotonic dystrophy. Family members can help by researching available trials online through clinical trial registries, contacting patient organizations like the Myotonic Dystrophy Foundation that maintain information about current research, connecting with specialized medical centers that conduct myotonic dystrophy research, and helping organize and understand information about different trial options. Having extra eyes and ears focused on research opportunities increases the likelihood of finding suitable studies.[15]

Practical support during trial participation makes a significant difference. Clinical trials often require frequent visits to research centers, which may be located far from home. Transportation assistance becomes essential, whether driving the person to appointments, arranging rideshare services, or planning overnight stays near the research site. Family members can attend appointments to help remember information shared by research staff, take notes, and ask questions. Managing study medications, tracking symptoms, and completing required paperwork are tasks where family assistance proves invaluable.[15]

Emotional support matters enormously when someone participates in clinical research. Hope mingles with uncertainty—hope that the treatment might help, but uncertainty about whether it will work and concern about possible side effects. Family members who listen without judgment, acknowledge these mixed feelings, and provide encouragement during difficult moments help sustain participation through challenging times. Celebrating the contribution being made to scientific knowledge, regardless of individual benefit, helps maintain perspective.[15]

Decision-making about trial participation benefits from family involvement while respecting the person’s autonomy. Discussing the potential benefits, risks, and practical implications together helps ensure well-considered decisions. Family members might raise questions or concerns the person with myotonic dystrophy hadn’t considered. However, the final decision must rest with the person who will be participating, and family support means respecting their choice even if other family members might have chosen differently.[15]

Understanding that participation helps everyone with myotonic dystrophy provides motivation during demanding trial periods. Even if a particular experimental treatment doesn’t work, the data gathered contributes to scientific understanding. Researchers learn what doesn’t work, which helps refine future approaches. Some trials don’t test treatments at all but simply collect information about how the disease progresses naturally, which is essential for designing better studies in the future. Every participant moves the field forward.[15]

Communication with research teams benefits from family involvement. Medical terminology and complex protocols can be confusing, especially for someone dealing with fatigue and cognitive changes that often accompany myotonic dystrophy. Having a family member present during study visits ensures someone else hears the information, can help clarify instructions later, and can advocate if concerns arise. Research staff appreciate family members who are engaged and informed partners in the research process.[15]

Financial considerations around clinical trial participation deserve family discussion. While participants typically don’t pay for experimental treatments being tested, there may be costs for travel, lodging, meals, and time away from work. Some trials offer reimbursement for these expenses, but not all do. Families need to realistically assess whether they can manage these practical and financial demands before committing to a trial, particularly one requiring frequent visits over extended periods.[15]

Staying informed about myotonic dystrophy research helps families identify trial opportunities and understand what researchers are working toward. Reading newsletters from patient organizations, attending conferences or webinars about research progress, connecting with the myotonic dystrophy community online, and maintaining relationships with specialized clinicians who know about current studies keeps families in the loop. This ongoing connection to the research world ensures families are well-positioned when relevant trials open for enrollment.[15]

Joining patient registries represents another way families can support research participation. Many registries collect information from people with myotonic dystrophy and their families, creating databases that researchers use to understand the disease better and to identify potential participants for future trials. Registry participation is usually simple, requiring periodic surveys but no travel or medical procedures. Family members can help ensure registry information stays current and complete.[15]

💊 Registered drugs used for this disease

List of officially registered medicines that are used in the treatment of this condition, based only on the provided sources:

  • Mexiletine – An anti-myotonic medication used to help relax muscles when myotonia impairs normal activities
  • Carbamazepine – An anti-myotonic drug that can help relieve muscle stiffness and inability to relax muscles after contraction
  • Nonsteroidal anti-inflammatory drugs (NSAIDs) – Used to manage muscle pain associated with myotonic dystrophy
  • Tricyclic antidepressants – Prescribed to treat pain and may also help address depression in people with myotonic dystrophy
  • Anti-diabetic drugs – Used to normalize blood sugar levels in patients who develop diabetes as a complication of the disease

Ongoing Clinical Trials on Myotonic dystrophy

  • Study Comparing the Safety and Effectiveness of Mexiletine PR and Mexiletine IR for Adults with Non-Dystrophic Myotonias

    Recruiting

    1 1 1 1
    Investigated diseases:
    Belgium France Germany Italy
  • Long-Term Safety and Efficacy Study of Mexiletine Hydrochloride for Patients with Myotonic Dystrophy Type 1 and Type 2

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium Denmark Germany Italy Spain
  • Study on the Effects of Mexiletine for Treating Myotonic Dystrophy Types 1 and 2 in Patients

    Recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Belgium Denmark Germany Italy Spain
  • Study on Long-Term Safety and Efficacy of VX-670 for Adults with Myotonic Dystrophy Type I

    Recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Belgium France Germany Italy The Netherlands Spain
  • Study on the Safety of VX-670 for Adults with Myotonic Dystrophy Type 1

    Recruiting

    Investigated diseases:
    Investigated drugs:
    Belgium France Germany Italy The Netherlands Spain
  • Study on ATX-01 for Adults Aged 18-64 with Myotonic Dystrophy Type 1 (DM1)

    Recruiting

    Investigated diseases:
    France Italy The Netherlands Spain
  • A study to evaluate the efficacy and safety of DYNE-101 in patients with Myotonic Dystrophy Type 1

    Not yet recruiting

    1 1 1
    Investigated diseases:
    Belgium Denmark France Germany Italy The Netherlands +1
  • A study testing the safety and effects of ADS-019 in adults aged 18 to 65 years with type 1 myotonic dystrophy

    Not yet recruiting

    Investigated diseases:
    Investigated drugs:
    Belgium Germany Italy Spain

References

https://my.clevelandclinic.org/health/diseases/24516-myotonic-dystrophy-dm

https://www.mda.org/disease/myotonic-dystrophy

https://www.ncbi.nlm.nih.gov/books/NBK557446/

https://medlineplus.gov/genetics/condition/myotonic-dystrophy/

https://en.wikipedia.org/wiki/Myotonic_dystrophy

https://www.mayoclinic.org/diseases-conditions/muscular-dystrophy/symptoms-causes/syc-20375388

https://my.clevelandclinic.org/health/diseases/24516-myotonic-dystrophy-dm

https://www.myotonic.org/what-dm-treatment-or-therapies-are-available

https://www.ncbi.nlm.nih.gov/books/NBK557446/

https://www.mda.org/disease/myotonic-dystrophy/medical-management/adult-dm1-dm2-juvenile-dm1

https://pmc.ncbi.nlm.nih.gov/articles/PMC11618391/

https://www.myotonic.org/living-myotonic-dystrophy

https://pmc.ncbi.nlm.nih.gov/articles/PMC3158552/

https://my.clevelandclinic.org/health/diseases/24516-myotonic-dystrophy-dm

https://www.myotonic.org/myotonic-dystrophy-start-your-journey-here

FAQ

Can myotonic dystrophy be cured?

There is currently no cure for myotonic dystrophy. However, many treatments and therapies are available to help manage symptoms and improve quality of life. These include medications for myotonia and pain, devices like pacemakers for heart problems, physical therapy for muscle weakness, and various assistive devices to maintain independence.

Will I pass myotonic dystrophy to my children?

Myotonic dystrophy is inherited in an autosomal dominant pattern, which means each child of an affected parent has a 50% chance of inheriting the genetic mutation. The disease can worsen with each generation due to a phenomenon called anticipation, where the number of DNA repeats increases when passed to children. Genetic counseling can help families understand their specific risks.

How long does it take to get diagnosed with myotonic dystrophy?

Studies show that people with myotonic dystrophy often experience a seven-year delay from when symptoms first appear to receiving an accurate diagnosis. This lengthy delay occurs because the condition causes such varied symptoms affecting multiple body systems, and many doctors are unfamiliar with the disease. Genetic testing can confirm the diagnosis definitively once myotonic dystrophy is suspected.

Is it safe for me to have surgery if I have myotonic dystrophy?

Surgery can be safely performed in people with myotonic dystrophy, but it requires extra precautions. General anesthesia poses unusually high risks, including complications and even death, even in people with mild symptoms. It is absolutely critical to inform your entire surgical team, especially the anesthesiologist, about your diagnosis well before any procedure. Certain medications like succinylcholine must be avoided, and careful cardiac and respiratory monitoring is essential before, during, and after surgery.

What is the difference between myotonic dystrophy type 1 and type 2?

Both types of myotonic dystrophy share many symptoms including muscle weakness, myotonia, and effects on multiple body systems. However, type 1 tends to be more severe and commonly affects muscles farthest from the body’s center (hands, feet, face), while type 2 is generally milder and primarily affects muscles closer to the body’s center (shoulders, hips, neck). Type 1 is caused by mutations in the DMPK gene, while type 2 results from mutations in the CNBP gene. Type 1 is more common in most populations.

🎯 Key takeaways

  • Myotonic dystrophy is far more common than previously thought, affecting about 1 in 2,100 people, with many cases remaining undiagnosed for years
  • Life expectancy is significantly reduced in myotonic dystrophy type 1, with respiratory and cardiac complications being the leading causes of early death
  • The disease affects much more than muscles—it impacts the heart, lungs, eyes, digestive system, hormones, and brain function
  • General anesthesia poses serious risks even for people with mild symptoms, requiring special precautions during any surgical procedure
  • Severity varies enormously between individuals—some people experience only mild symptoms while others face severe progressive disability
  • Heart rhythm problems can occur suddenly without warning, making regular cardiac monitoring essential regardless of symptom severity
  • Excessive daytime sleepiness affects many patients and can be dangerous when driving or operating machinery
  • Clinical trials offer hope for future treatments, and family support greatly enhances successful research participation